Medivir AB (FRA:MVR0)
€ 0.211 -0.017 (-7.46%) Market Cap: 27.91 Mil Enterprise Value: 14.54 Mil PE Ratio: 0 PB Ratio: 1.77 GF Score: 46/100

Q1 2021 Medivir AB Earnings Call Transcript

Apr 28, 2021 / 12:00PM GMT
Release Date Price: €0.652092 (+0.39%)
Operator

Ladies and gentlemen, welcome to the Medivir AB Q1 Report 2021. (Operator Instructions) Today, I'm pleased to present Yilmaz Mahshid, CEO; Magnus Christensen, CFO; and Fredrik Ãberg, CSO. Please begin your meeting.

Yilmaz Mahshid;publ;CEO;President
Medivir AB

()-&

Thank you, operator, and warm welcome to everyone joining this call. Medivir's first quarter numbers and highlights, Slide #3, please, operator. You will find our presentation on our homepage, and I do recommend everyone to read our cautionary statement, which you find on Slide #3.

Let's jump to Slide #5, please. We will briefly present an overview of the company's main projects and partners and highlight a few numbers for the first quarter. To be continued with our CFO, Magnus will present the broader picture of our, what we believe, strong financial position, followed by an update on our recently announced partnerships. Then we'll be touching up on our 818 project for liver cancer and round up the presentation with a Q&A.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot